BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38834088)

  • 1. Small steps can lead to substantial breakthroughs: moving the therapeutic needle forward in pancreatic cancer.
    Pathak P; Weekes C; Wo JY
    Lancet Oncol; 2024 Jul; 25(7):824-825. PubMed ID: 38834088
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspectives in chemotherapy of pancreatic cancer.
    Klapdor R
    Eur J Surg Oncol; 1991 Apr; 17(2):153-66. PubMed ID: 1707835
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preoperative chemoradiation for pancreatic cancer].
    Nakamura S
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():159-62. PubMed ID: 25857006
    [No Abstract]   [Full Text] [Related]  

  • 4. [Palliative chemotherapy for pancreatic cancer].
    Buscail L; Bournet B; Guimbaud R
    Gastroenterol Clin Biol; 2006 Jan; 30(1):106-9. PubMed ID: 16514388
    [No Abstract]   [Full Text] [Related]  

  • 5. [Systemic chemotherapy for unresectable pancreatic cancer].
    Naruge D; Nagashima F; Furuse J
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():148-51. PubMed ID: 25857004
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreatic cancer: between bench and bedside.
    Melisi D; Budillon A
    Curr Drug Targets; 2012 Jun; 13(6):729-30. PubMed ID: 22458518
    [No Abstract]   [Full Text] [Related]  

  • 7. Perioperative chemotherapy with modified FOLFIRINOX for nonmetastatic pancreatic cancer: a new standard of care?
    Radi I; Samaha R; El Hajj J; Samaha H; Kourie HR
    Future Oncol; 2021 Jan; 17(3):229-233. PubMed ID: 33305614
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of preoperative chemotherapy on apoptosis and tissues of pancreatic adenocarcinoma].
    Liao Q; Zhao Y; Cai L; Chen J; Liu T; Zhu Y
    Zhonghua Wai Ke Za Zhi; 1999 Mar; 37(3):146-8, 7. PubMed ID: 11829805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of pancreatic cancer].
    Mizumoto R; KitaT
    Gan No Rinsho; 1989 Jan; Spec No():329-36. PubMed ID: 2915484
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of advanced pancreatic cancer.
    Labianca R; Merelli B; Mosconi S
    Ann Oncol; 2012 Sep; 23 Suppl 10():x139-40. PubMed ID: 22987950
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neoadjuvant therapy vs. upfront resection for resectable pancreatic cancer].
    Strobel O; Büchler MW
    Chirurg; 2017 Jul; 88(7):619. PubMed ID: 28573533
    [No Abstract]   [Full Text] [Related]  

  • 12. Occipital Headache as Initial Manifestation of a Pancreatic Neuroendocrine Tumor.
    Tsoukalas N; Triantafyllidis A; Tolia M; Galanopoulos M; Kostakis ID; Demiri S; Toumpanakis C; Koumakis G
    J Gastrointest Cancer; 2018 Dec; 49(4):501-503. PubMed ID: 28283989
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of locally advanced pancreatic cancer with FOLFIRINOX].
    Strobel O; Büchler MW
    Chirurg; 2016 Aug; 87(8):699. PubMed ID: 27418266
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of neoadjuvant therapy in management of pancreatic cancer.
    Li J; Saif MW
    JOP; 2014 Jul; 15(4):354-7. PubMed ID: 25076342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy and radiotherapy for inoperable pancreatic cancer. A survey of a Cochrane review].
    Bjerregaard JK; Pfeiffer P
    Ugeskr Laeger; 2007 Nov; 169(46):3949-52. PubMed ID: 18078646
    [No Abstract]   [Full Text] [Related]  

  • 16. Advanced pancreatic cancer--5 years on.
    Rao S; Cunningham D
    Ann Oncol; 2002 Aug; 13(8):1165-8. PubMed ID: 12181237
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment strategy for pancreatic endocrine tumours].
    Mitry E; Rougier P
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S31-6. PubMed ID: 12704291
    [No Abstract]   [Full Text] [Related]  

  • 18. Pancreatic cancer.
    Gyllenhaal C; Alschuler L; Rubin D; Kranz S; Roddy GD; Block KI
    Integr Cancer Ther; 2008 Jun; 7(2):103-13. PubMed ID: 18505898
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-metastatic Pancreatic Cancer: Resectable, Borderline Resectable, and Locally Advanced-Definitions of Increasing Importance for the Optimal Delivery of Multimodality Therapy.
    Evans DB; George B; Tsai S
    Ann Surg Oncol; 2015 Oct; 22(11):3409-13. PubMed ID: 26122369
    [No Abstract]   [Full Text] [Related]  

  • 20. Pancreatic small cell cancer.
    El Rassy E; Tabchi S; Kourie HR; Assi T; Chebib R; Farhat F; Kattan J
    Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):276-280. PubMed ID: 26566245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.